Showing results (181-190 of 307) with videos related to
Sort By:
Pageof 31
Neurology|September 10, 2013
Randomized trial of cognitive speed of processing training in Parkinson diseaseJerri D Edwards, Robert A Hauser, Melissa L O'Connor, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 20, 2016
Long-term effects of rasagiline and the natural history of treated Parkinson's diseaseOlivier Rascol, Robert A Hauser, Fabrizio Stocchi, et al.Clinical Trials (London, England)|August 31, 2016
Communicating with participants during the conduct of multi-center clinical trialsErika F Augustine, E Ray Dorsey, Robert A Hauser, et al.The International Journal of Neuroscience|January 19, 2018
A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystoniaMark F Lew, Allison Brashear, Khashayar Dashtipour, et al.Parkinsonism & Related Disorders|May 2, 2021
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsStuart H Isaacson, Clive G Ballard, David L Kreitzman, et al.Neurology and Therapy|February 22, 2022
Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson's Disease: Clinical Trial Post Hoc AnalysesRajesh Pahwa, Jason Aldred, Niodita Gupta, et al.Journal of Parkinson'S Disease|February 20, 2025
Continuous, subcutaneous apomorphine infusion for Parkinson disease motor fluctuations: Results from the phase 3, long-term, open-label United States InfusON studyStuart H Isaacson, Alberto J Espay, Rajesh Pahwa, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 9, 2015
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled studyChristopher F O'Brien, Roland Jimenez, Robert A Hauser, et al.Movement Disorders : Official Journal of the Movement Disorder Society|August 10, 2004
Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patientsMatthew B Stern, Kenneth L Marek, Joseph Friedman, et al.Parkinsonism & Related Disorders|January 21, 2024
Intrinsic auricular muscle zone stimulation for Parkinson disease: The EARSTIM-PD Phase II multi-center pilot study resultsHubert H Fernandez, Eric A Macklin, Robert A Hauser, et al.Pageof 31